The Sindh Drug Testing Laboratory in Karachi has issued a public health alert regarding nine cancer treatment medicines identified as fake and substandard. Laboratory findings indicated that some of these medicines lacked essential active ingredients necessary for effective cancer treatment.
Syed Adnan Rizvi, Director of the Sindh Drug Testing Laboratory, noted that these medicines were not registered with the Drug Regulatory Authority of Pakistan (DRAP). This raises serious concerns about their potential entry into the market through illegal channels, including black-market networks and smuggling.
The laboratory report revealed that several injections and tablets did not contain the active pharmaceutical ingredients needed to halt the growth of cancer cells. Health experts have warned that using counterfeit and substandard medicines can significantly diminish treatment effectiveness, reduce recovery chances, and pose serious risks to patients’ lives.
Authorities are urging the public, healthcare providers, and pharmacies to remain vigilant and avoid purchasing or using unregistered or counterfeit medicines. Patients are advised to obtain cancer medications solely from licensed pharmacies and to verify the authenticity of medicines through approved regulatory channels.
This alert highlights the critical need for stringent regulatory oversight and public awareness to prevent the circulation of counterfeit medicines that endanger patient safety and public health.
Disclaimer: This news graphic contains an AI-generated image created solely for illustrative purposes. It does not depict any actual patient, healthcare professional, medicine, laboratory, or incident. The accompanying news report is based on publicly available information and official statements. Readers are advised to rely on updates issued by the relevant health authorities, including the Drug Regulatory Authority of Pakistan (DRAP) and the Sindh Drug Testing Laboratory, and to purchase medicines only from licensed pharmacies.
